Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20830287rdf:typepubmed:Citationlld:pubmed
pubmed-article:20830287lifeskim:mentionsumls-concept:C0027361lld:lifeskim
pubmed-article:20830287lifeskim:mentionsumls-concept:C1308752lld:lifeskim
pubmed-article:20830287lifeskim:mentionsumls-concept:C0005516lld:lifeskim
pubmed-article:20830287lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:20830287lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:20830287lifeskim:mentionsumls-concept:C1367714lld:lifeskim
pubmed-article:20830287lifeskim:mentionsumls-concept:C1706327lld:lifeskim
pubmed-article:20830287lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:20830287lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:20830287lifeskim:mentionsumls-concept:C0443131lld:lifeskim
pubmed-article:20830287pubmed:issue9lld:pubmed
pubmed-article:20830287pubmed:dateCreated2010-9-10lld:pubmed
pubmed-article:20830287pubmed:abstractTextThe suboptimal sensitivity of Interferon (IFN)-?-based in-vitro assays, especially in immunocompromised individuals, emphasizes the need for alternative markers for diagnosing tuberculosis (TB). The objective of this study was to evaluate whether interferon-inducible protein (IP)-10, monocyte chemotactic protein (MCP)-2 and interleukin (IL)-2 can be useful biomarkers for evaluating a specific response to RD1 antigens associated to active TB disease in HIV-infected individuals.lld:pubmed
pubmed-article:20830287pubmed:languageenglld:pubmed
pubmed-article:20830287pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20830287pubmed:citationSubsetIMlld:pubmed
pubmed-article:20830287pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20830287pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20830287pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20830287pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20830287pubmed:statusMEDLINElld:pubmed
pubmed-article:20830287pubmed:issn1932-6203lld:pubmed
pubmed-article:20830287pubmed:authorpubmed-author:RodriguesCami...lld:pubmed
pubmed-article:20830287pubmed:authorpubmed-author:GolettiDeliaDlld:pubmed
pubmed-article:20830287pubmed:authorpubmed-author:IppolitoGiuse...lld:pubmed
pubmed-article:20830287pubmed:authorpubmed-author:AlameluRajaRlld:pubmed
pubmed-article:20830287pubmed:authorpubmed-author:VernetGuyGlld:pubmed
pubmed-article:20830287pubmed:authorpubmed-author:LagrangePhili...lld:pubmed
pubmed-article:20830287pubmed:authorpubmed-author:GirardiEnrico...lld:pubmed
pubmed-article:20830287pubmed:authorpubmed-author:CarraraStefan...lld:pubmed
pubmed-article:20830287pubmed:authorpubmed-author:LeportierMarc...lld:pubmed
pubmed-article:20830287pubmed:authorpubmed-author:SodhaArchanaAlld:pubmed
pubmed-article:20830287pubmed:authorpubmed-author:Syed Ahamed...lld:pubmed
pubmed-article:20830287pubmed:authorpubmed-author:LonguetChrist...lld:pubmed
pubmed-article:20830287pubmed:authorpubmed-author:ThangarajSath...lld:pubmed
pubmed-article:20830287pubmed:issnTypeElectroniclld:pubmed
pubmed-article:20830287pubmed:volume5lld:pubmed
pubmed-article:20830287pubmed:ownerNLMlld:pubmed
pubmed-article:20830287pubmed:authorsCompleteYlld:pubmed
pubmed-article:20830287pubmed:paginatione12577lld:pubmed
pubmed-article:20830287pubmed:meshHeadingpubmed-meshheading:20830287...lld:pubmed
pubmed-article:20830287pubmed:meshHeadingpubmed-meshheading:20830287...lld:pubmed
pubmed-article:20830287pubmed:meshHeadingpubmed-meshheading:20830287...lld:pubmed
pubmed-article:20830287pubmed:meshHeadingpubmed-meshheading:20830287...lld:pubmed
pubmed-article:20830287pubmed:meshHeadingpubmed-meshheading:20830287...lld:pubmed
pubmed-article:20830287pubmed:meshHeadingpubmed-meshheading:20830287...lld:pubmed
pubmed-article:20830287pubmed:meshHeadingpubmed-meshheading:20830287...lld:pubmed
pubmed-article:20830287pubmed:meshHeadingpubmed-meshheading:20830287...lld:pubmed
pubmed-article:20830287pubmed:meshHeadingpubmed-meshheading:20830287...lld:pubmed
pubmed-article:20830287pubmed:meshHeadingpubmed-meshheading:20830287...lld:pubmed
pubmed-article:20830287pubmed:meshHeadingpubmed-meshheading:20830287...lld:pubmed
pubmed-article:20830287pubmed:meshHeadingpubmed-meshheading:20830287...lld:pubmed
pubmed-article:20830287pubmed:year2010lld:pubmed
pubmed-article:20830287pubmed:articleTitleIs IP-10 an accurate marker for detecting M. tuberculosis-specific response in HIV-infected persons?lld:pubmed
pubmed-article:20830287pubmed:affiliationTranslational Research Unit, Department of Epidemiology and Preclinical Research, Lazzaro Spallanzani National Institute for Infectious Diseases (INMI), Rome, Italy. delia.goletti@inmi.itlld:pubmed
pubmed-article:20830287pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20830287pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed